Skip to content

Drug interactions

Cobimetinib + Efavirenz

Severity: Contraindicated

Cobimetinib and Efavirenz: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz induces CYP3A4 and can markedly lower cobimetinib exposure. This may lead to loss of antitumour efficacy.

What this interaction means in plain words

Cobimetinib and Efavirenz are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Cobimetinib belongs to Oncology; Efavirenz belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Induction of CYP3A4-mediated metabolism of cobimetinib by efavirenz.

What to do

Avoid the combination and use an alternative antiretroviral without enzyme-inducing properties. If it cannot be avoided, seek oncology and HIV specialist input.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cobimetinib and Efavirenz, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Cobimetinib with Efavirenz?

MediHelp rates the interaction as contraindicated. Cobimetinib and Efavirenz are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Efavirenz induces CYP3A4 and can markedly lower cobimetinib exposure. This may lead to loss of antitumour efficacy.

How serious is the interaction between Cobimetinib and Efavirenz?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and use an alternative antiretroviral without enzyme-inducing properties. If it cannot be avoided, seek oncology and HIV specialist input.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Dienogest / estradiol valerate, Dihydroergotamine intranasal, Dihydroergotamine. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in